Nov. 14, 2024 14:22 PM EST
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.
Biogen said Thursday that the drug, known in the U.S. as Leqembi, received a positive opinion from the European Medicines Agency’s Committee for...
Oct. 23, 2024 07:06 AM EDT
LONDON (AP) — Britain's drug regulator approved the Alzheimer's drug Kisunla on Wednesday, but the government won't be paying for it after an independent watchdog agency said the treatment isn't worth the cost to taxpayers.
It is the second Alzheimer's drug to receive such a mixed...
Oct. 07, 2024 18:00 PM EDT
WASHINGTON (AP) — A unique peek inside the human brain may help explain how it clears away waste like the kind that can build up and lead to Alzheimer’s disease.
Brain cells use a lot of nutrients which means they make a lot of waste. Scientists have long thought the brain has...